Exchange: NYSE·Updated 07:58 PM EDT

ENOV News

News
all
press releases
What Makes Enovis (ENOV) a New Buy Stock
Enovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
More News
Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Enovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks
Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition
ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.
Zacks
eCential Robotics Announces Binding Offer from Enovis
eCential Robotics Announces Binding Offer from Enovis eCential Robotics Announces Binding Offer from Enovis PR Newswire GRENOBLE, France and FRANKLIN, Tenn., Sept. 1, 2026 eCential Robotics platform to join Enovis' enabling technology portfolio.GRENOBLE, France and FRANKLIN, Tenn., Sept. 1, 2026...
PR Newswire
Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates
Enovis (ENOV) delivered earnings and revenue surprises of +8.43% and +0.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Carlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue Estimates
Carlsmed, Inc. (CARL) delivered earnings and revenue surprises of +2.50% and +2.27%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Tuesday Sector Laggards: Medical Instruments & Supplies, Cigarettes & Tobacco Stocks
In trading on Tuesday, medical instruments & supplies shares were relative laggards, down on the day by about 2.5%. Helping drag down the group were shares of Enovis, off about 11.2% and shares of Quanterix off about 9% on the day. Also lagging the market Tuesday are cigar...
Nasdaq News: Markets
Brookdale Senior May 2026 Occupancy Volume Rises to 82.5%
BKD's occupancy climbs to 82.5% in May, extending a four-quarter growth streak and supporting its 2026 revenue and EBITDA outlook.
Zacks
Veeva's Falcon and Vault AI: When Could AI Become a Revenue Driver?
VEEV's Falcon and Vault AI deepen workflow automation across life sciences, while management expects AI revenues to remain immaterial in fiscal 2027.
Zacks
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now?
Key PointsFund increased Enovis stake by 384,124 shares; estimated trade size was $9.08 million based on quarterly average price...
Nasdaq News: Markets

Advertisement|Remove ads.